FanJSongYChenY, et al.Combined effect of obesity and cardiometabolic abnormality on the risk of cardiovascular disease: A meta-analysis of prospective cohort studies. Int J Cardiol2013; 168: 4761–4768.
2.
MatsuzawaYLermanA. Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coron Artery Dis2014; 25: 713–724.
3.
PiepoliMFHoesAWAgewallS, et al.2016 European Guidelines on cardiovascular disease prevention in clinical practice: Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol2016; 23: NP1–NP96.
4.
CavallariICannonCPBraunwaldE, et al.Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome. Eur J Prev Cardiol2018; 25: 830–838.
5.
Romero-CorralAMontoriVMSomersVK, et al.Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies. Lancet2006; 368: 666–678.
6.
FoxCSMassaroJMHoffmannU, et al.Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation2007; 116: 39–48.
7.
DespresJPLemieuxI. Abdominal obesity and metabolic syndrome. Nature2006; 444: 881–887.
8.
HanselBRousselRElbezY, et al.Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis. Eur Heart J2015; 36: 2716–2728.
9.
Sawada N, Nakanishi K, Daimon M, et al. Influence of visceral adiposity accumulation on adverse left and right ventricular mechanics in the community. Eur J Prev Cardiol. 2020; 27: 2006–2015.
10.
Mohammadi H, Ohm J, Discacciati A, et al. Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction. Eur J Prev Cardiol 2020; 27: 1944–1952.
